Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Mølck

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The International Journal of Biostatistics|July 8, 2018
A Spatio-Temporal Model and Inference Tools for Longitudinal Count Data on Multicolor Cell GrowthPuXue Qiao, Christina Mølck, Davide Ferrari, et al.
Oncotarget|June 11, 2016
High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cellsJinhan Xie, Christina Mølck, Sophie Paquet-Fifield, et al.
International Journal of Molecular Sciences|December 6, 2018
Targeting Adenosine Receptor Signaling in Cancer ImmunotherapyKevin Sek, Christina Mølck, Gregory D Stewart, et al.
Neurochemical Research|February 5, 2014
mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discoveryChristina Mølck, Kasper Harpsøe, David E Gloriam, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 9, 2023
Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 ComplexMaxim A X Tollenaere, Christina Mølck, Ian Henderson, et al.
Cancer Letters|October 4, 2016
The A<sub>2b</sub> adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanismChristina Mølck, James Ryall, Laura M Failla, et al.
Clinical & Experimental Metastasis|January 17, 2018
Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous processCorina Behrenbruch, Carolyn Shembrey, Sophie Paquet-Fifield, et al.
Cancers|February 15, 2022
Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour ModelsCarolyn Shembrey, Jai Smith, Mélodie Grandin, et al.
Molecular Pharmacology|August 18, 2012
Pharmacological characterization and modeling of the binding sites of novel 1,3-bis(pyridinylethynyl)benzenes as metabotropic glutamate receptor 5-selective negative allosteric modulatorsChristina Mølck, Kasper Harpsøe, David E Gloriam, et al.
Chemmedchem|January 24, 2012
Structure-activity relationships for negative allosteric mGluR5 modulatorsBirgitte H Kaae, Kasper Harpsøe, Trine Kvist, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The International Journal of Biostatistics|July 8, 2018
A Spatio-Temporal Model and Inference Tools for Longitudinal Count Data on Multicolor Cell GrowthPuXue Qiao, Christina Mølck, Davide Ferrari, et al.
Oncotarget|June 11, 2016
High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cellsJinhan Xie, Christina Mølck, Sophie Paquet-Fifield, et al.
International Journal of Molecular Sciences|December 6, 2018
Targeting Adenosine Receptor Signaling in Cancer ImmunotherapyKevin Sek, Christina Mølck, Gregory D Stewart, et al.
Neurochemical Research|February 5, 2014
mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discoveryChristina Mølck, Kasper Harpsøe, David E Gloriam, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 9, 2023
Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 ComplexMaxim A X Tollenaere, Christina Mølck, Ian Henderson, et al.
Cancer Letters|October 4, 2016
The A<sub>2b</sub> adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanismChristina Mølck, James Ryall, Laura M Failla, et al.
Clinical & Experimental Metastasis|January 17, 2018
Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous processCorina Behrenbruch, Carolyn Shembrey, Sophie Paquet-Fifield, et al.
Cancers|February 15, 2022
Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour ModelsCarolyn Shembrey, Jai Smith, Mélodie Grandin, et al.
Molecular Pharmacology|August 18, 2012
Pharmacological characterization and modeling of the binding sites of novel 1,3-bis(pyridinylethynyl)benzenes as metabotropic glutamate receptor 5-selective negative allosteric modulatorsChristina Mølck, Kasper Harpsøe, David E Gloriam, et al.
Chemmedchem|January 24, 2012
Structure-activity relationships for negative allosteric mGluR5 modulatorsBirgitte H Kaae, Kasper Harpsøe, Trine Kvist, et al.
Pageof 2